These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1660911)
1. Suppression of human macrophage function in vitro by delta 9-tetrahydrocannabinol. Specter S; Lancz G; Goodfellow D J Leukoc Biol; 1991 Nov; 50(5):423-6. PubMed ID: 1660911 [TBL] [Abstract][Full Text] [Related]
2. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. Lopez-Cepero M; Friedman M; Klein T; Friedman H J Leukoc Biol; 1986 Jun; 39(6):679-86. PubMed ID: 3011935 [TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of delta 9-tetrahydrocannabinol in vitro on phagocytosis by murine macrophages. Friedman M; Cepero ML; Klein T; Friedman H Proc Soc Exp Biol Med; 1986 Jun; 182(2):225-8. PubMed ID: 3010329 [TBL] [Abstract][Full Text] [Related]
4. Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic activity of the murine macrophage cell line, P388D1. Tang JL; Lancz G; Specter S; Bullock H Int J Immunopharmacol; 1992 Feb; 14(2):253-62. PubMed ID: 1320592 [TBL] [Abstract][Full Text] [Related]
5. Suppression of lymphocyte adenosine 3':5'-cyclic monophosphate (cAMP) by delta-9-tetrahydrocannabinol. Diaz S; Specter S; Coffey RG Int J Immunopharmacol; 1993 May; 15(4):523-32. PubMed ID: 8396073 [TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol. Burnette-Curley D; Cabral GA Proc Soc Exp Biol Med; 1995 Oct; 210(1):64-76. PubMed ID: 7675800 [TBL] [Abstract][Full Text] [Related]
8. Delta-9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes. Trisler K; Specter S Int J Immunopharmacol; 1994 Jul; 16(7):593-603. PubMed ID: 7523319 [TBL] [Abstract][Full Text] [Related]
9. Marijuana effects on immunity: suppression of human natural killer cell activity of delta-9-tetrahydrocannabinol. Specter SC; Klein TW; Newton C; Mondragon M; Widen R; Friedman H Int J Immunopharmacol; 1986; 8(7):741-5. PubMed ID: 3023245 [TBL] [Abstract][Full Text] [Related]
10. Normal lymphocyte function in the presence of delta-9-tetrahydrocannabinol. Rachelefsky GS; Opelz G Clin Pharmacol Ther; 1977 Jan; 21(1):44-6. PubMed ID: 137796 [TBL] [Abstract][Full Text] [Related]
11. Enhanced growth of Legionella pneumophila in tetrahydrocannabinol-treated macrophages. Arata S; Newton C; Klein T; Friedman H Proc Soc Exp Biol Med; 1992 Jan; 199(1):65-7. PubMed ID: 1309398 [TBL] [Abstract][Full Text] [Related]
12. Tetrahydrocannabinol treatment suppresses growth restriction of Legionella pneumophila in murine macrophage cultures. Arata S; Klein TW; Newton C; Friedman H Life Sci; 1991; 49(6):473-9. PubMed ID: 1650875 [TBL] [Abstract][Full Text] [Related]
14. Delta9-tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expression. Clements DJ; Matveyeva M; McCoy KL Int J Immunopharmacol; 1998 Aug; 20(8):415-28. PubMed ID: 9778102 [TBL] [Abstract][Full Text] [Related]
15. Δ-Tetrahydrocannabinol induces cytotoxicity in macrophage J774-1 cells: involvement of cannabinoid receptor 2 and p38 MAPK. Yamaori S; Ishii H; Chiba K; Yamamoto I; Watanabe K Toxicology; 2013 Dec; 314(2-3):254-61. PubMed ID: 24184660 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of alveolar macrophage spreading and phagocytosis by cotton bract tannin. A potential mechanism in the pathogenesis of byssinosis. Kreofsky TJ; Russell JA; Rohrbach MS Am J Pathol; 1990 Aug; 137(2):263-74. PubMed ID: 2117397 [TBL] [Abstract][Full Text] [Related]
17. Δ⁹-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood. Moretti S; Castelli M; Franchi S; Raggi MA; Mercolini L; Protti M; Somaini L; Panerai AE; Sacerdote P J Leukoc Biol; 2014 Oct; 96(4):523-34. PubMed ID: 24744434 [TBL] [Abstract][Full Text] [Related]
18. Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Schatz AR; Koh WS; Kaminski NE Immunopharmacology; 1993; 26(2):129-37. PubMed ID: 8282537 [TBL] [Abstract][Full Text] [Related]
19. Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection. Williams JC; Appelberg S; Goldberger BA; Klein TW; Sleasman JW; Goodenow MM J Neuroimmune Pharmacol; 2014 Jun; 9(3):369-79. PubMed ID: 24562630 [TBL] [Abstract][Full Text] [Related]
20. The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses. Klein TW; Newton CA; Widen R; Friedman H J Immunopharmacol; 1985; 7(4):451-66. PubMed ID: 3003204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]